Aluminium nicotinate: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)
ShiSheng (talk | contribs)
No edit summary
Line 24: Line 24:
| routes_of_administration = Oral<ref>The Merck Index, 12th Edition. 364</ref>
| routes_of_administration = Oral<ref>The Merck Index, 12th Edition. 364</ref>
}}
}}
{{CMG}}
{{CMG}} {{AE}}{{SS}}




Line 35: Line 35:
{{Lipid modifying agents}}
{{Lipid modifying agents}}


[[Category:Nicotinates]]
[[Category:Aluminium compounds]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 15:34, 24 July 2014

Aluminium nicotinate
Clinical data
Routes of
administration
Oral[1]
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC18H12AlN3O6
Molar mass393.286 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]


Aluminium nicotinate is a niacin derivative used as a hypolipidemic agent.

References

  1. The Merck Index, 12th Edition. 364

Template:Lipid modifying agents


Template:WikiDoc Sources